Renal cell carcinoma
in adults 40 years old or less: Young age is an independent prognostic factor for cancer-specific survival.
TCCs are often found coexisting with other papillary renal neoplasms (both type 1 and type 2), including papillary renal cell carcinomas
and papillary adenomas.
Extensively cystic renal neoplasms: cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma
, and cystic hamartoma of renal pelvis.
In summary, we report an unusual histologic pattern of low Fuhrman nuclear grade clear cell renal cell carcinoma
with rich anastomosing vascularity and paucity of carcinoma cells.
Pfizer is pleased to provide Sutent to support immatic's clinical development program in advanced renal cell carcinoma
patients," said Craig Eagle, Vice President of Strategic Alliances and Partnerships for Pfizer Oncology.
Studies evaluating renal capsular involvement in renal cell carcinoma
Number of Follow-up Capsular Prognostic patients (Months) infiltration implication [n (%)] DSS RFS Present 79 31 26 (32.
Everolimus in Subjects With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma
Who Have Received Prior Anti-Angiogenic Therapy.
However, some trials have shown that the histologic subtype and morphologic features of renal cell carcinoma
can be important predictors of response to targeted therapy.
Current management of renal cell carcinoma
and targeted therapy.
Treatment outcome and survival associated with metastatic renal cell carcinoma
of non-clear-cell histology.
The association of tuberculosis and renal cell carcinoma
(RCC) is uncommon.
com has added a new market research report: Renal Cell Carcinoma
Global Clinical Trials Review, H1, 2014 http://www.